Avalon Globocare Faces Nasdaq Delisting Over Equity Rule Violation
Avalon Globocare Corp. has announced that it received a notice from the Nasdaq Stock Market indicating that the company is not in compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market. As of March 31, 2025, Avalon reported stockholders' equity of negative $3.89 million, falling short of the required $2.5 million. The company also failed to meet alternative standards for market value or net income. Nasdaq had previously granted Avalon an extension until November 18, 2025, to regain compliance, but the company has now received a second letter of non-compliance. Avalon plans to request a hearing before the Nasdaq Hearings Panel, which will temporarily prevent any suspension or delisting of its common stock pending a decision.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalon Globocare Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-113638), on November 21, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。